Skip to main
INGN
INGN logo

Inogen (INGN) Stock Forecast & Price Target

Inogen (INGN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

Inogen Inc reported a notable improvement in its financial metrics, with an adjusted EBITDA margin that increased by 1,850 basis points year-over-year, resulting in a negative margin of (4.4%) but demonstrating substantial operational progress. The company's operating margin also improved by 2,400 basis points year-over-year to (14.2%), outperforming consensus expectations of (18.7%). Furthermore, gross margins saw a significant increase of 820 basis points year-over-year to 45.3%, indicating robust growth in the company's B2B segment, which achieved a 28.1% increase in revenues, hinting at successful customer acquisitions and market share gains.

Bears say

Inogen Inc faces significant challenges, including anticipated slower revenue growth and worse-than-expected margins, which could contribute to a negative financial outlook. The company's direct-to-consumer business has experienced a notable decline of 19.1%, with both DTC sales and rentals suffering losses, further highlighting revenue generation challenges. Additionally, adjustments to future earnings projections indicate a worsening outlook for adjusted EBITDA, reflecting ongoing concerns about financial performance and competitive pressures in the market.

Inogen (INGN) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Inogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Inogen (INGN) Forecast

Analysts have given Inogen (INGN) a Buy based on their latest research and market trends.

According to 7 analysts, Inogen (INGN) has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $28.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $28.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Inogen (INGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.